The Effect of Thyrotropin-Receptor Blocking Antibodies on Stimulating Autoantibodies from Patients with Graves' Disease

Thyroid

Volumn 13, Issue 12, 2003, Pages 1153-1161

  Lenzner, Cornelia ^a   Morgenthaler, Nils G ^a,b  

^a BRAHMS AG   (Germany)

^b Brahms AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; AUTOANTIBODY; CYCLIC AMP; EPITOPE; LUCIFERASE; MONOCLONAL ANTIBODY; THYROID HORMONE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE INDUCTION; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REPORTER GENE; SIGNAL TRANSDUCTION; THYROID HORMONE SYNTHESIS;

EID: 0346102451     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/10507250360731569     Document Type: Article

References (33)

1. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin (TSH) receptor: Interaction with TSH and autoantibodies. Endocr Rev 19:673-716.
2. Weetman AP 2000 Graves' disease. N Engl J Med 343:1236-1248.
3. Chiovato L, Vitti P, Bendinelli G, Santini F, Fiore E, Capaccioli A, Tonacchera M, Mammoli C, Ludgate M, Pinchera A 1994 Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor. J Endocrinol Invest 17:809-816.
4. Khoo DH, Eng PH, Ho SC, Fok AC 1999 Differences in the levels of TSH-binding inhibitor immunoglobulins in goitrous and agoitrous autoimmune thyroiditis after twelve months of L-thyroxine therapy. Clin Endocrinol (Oxf) 51:73-79.
5. Costagliola S, Rodien P, Many MC, Ludgate M, Vassart G 1998 Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol 160:1458-1465.
6. Shepherd PS, Da Costa CR, Cridland JC, Gilmore KS, Johnstone AP 1999 Identification of an important thyrotrophin binding site on the human thyrotrophin receptor using monoclonal antibodies. Mol Cell Endocrinol 149:197-206.
7. Seetharamaiah GS, Dallas JS, Prabhakar BS 1999 Glycosylated ectodomain of the human thyrotropin receptor induces antibodies capable of reacting with multiple blocking antibody epitopes. Autoimmunity 29:21-31.
8. Oda Y, Sanders J, Evans M, Kiddie A, Munkley A, James C, Richards T, Wills J, Furmaniak J, Smith BR 2000 Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies. Thyroid 10:1051-1059.
9. Costagliola S, Panneels V, Bonomi M, Koch J, Many MC, Smits G, Vassart G 2002 Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J 21:504-513.
10. Ando T, Latif R, Pritsker A, Moran T, Nagayama Y, Davies TF 2002 A monoclonal thyroid-stimulating antibody. J Clin Invest 110:1667-1674.
11. Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, Brereton K, Groenen M, Oda Y, Furmaniak J, Rees Smith B 2002 Thyroid-stimulating monoclonal antibodies. Thyroid 12:1043-1050.
12. Costagliola S, Franssen JD, Bonomi M, Urizar E, Willnich M, Bergmann A, Vassart G 2002 Generation of a mouse monoclonal TSH receptor antibody with stimulating activity. Biochem Biophys Res Commun 299:891-896.
13. Morgenthaler NG, Pampel I, Aust G, Seissler J, Scherbaum WA 1998 Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor. Horm Metab Res 30:162-168.
14. Evans C, Morgenthaler NG, Lee S, Llewellyn DH, Clifton-Bligh R, John R, Lazarus JH, Chatterjee VK, Ludgate M 1999 Development of a luminescent bioassay for thyroid stimulating antibodies. J Clin Endocrinol Metab 84:374-377.
15. Jordan NJ, Rinderle C, Ashfield J, Morgenthaler NG, Lazarus J, Ludgate M, Evans C 2001 A luminescent bioassay for thyroid blocking antibodies. Clin Endocrinol (Oxf) 54:355-364.
16. Morgenthaler NG 1999 New assay systems for thyrotropin receptor antibodies. Curr Opin Endocrinol Diabetes 6:251-260.
17. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, Poertl S, Weglohner W, Hollidt JM, Quadbeck B, Dumont JE, Schumm-Draeger PM, Bergmann A, Mann K, Vassart G, Usadel KH 1999 Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 84:90-97.
18. Schott M, Feldkamp J, Bathan C, Fritzen R, Scherbaum WA, Seissler J 2000 Detecting TSH-receptor antibodies with the recombinant TBII assay: Technical and clinical evaluation. Horm Metab Res 32:429-435.
19. Nagayama Y, Wadsworth HL, Russo D, Chazenbalk GD, Rapoport B 1991 Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. J Clin Invest 88:336-340.
20. Tahara K, Ban T, Minegishi T, Kohn LD 1991 Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun 179:70-77.
21. Nagayama Y, Rapoport B 1992 Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: Selective role of receptor amino acids Ser25-Glu30. J Clin Endocrinol Metab 75:1425-1430.
22. Schwarz-Lauer L, Chazenbalk GD, McLachlan SM, Ochi Y, Nagayama Y, Rapoport B 2002 Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor. Thyroid 12:115-120.
23. Tahara K, Ishikawa N, Yamamoto K, Hirai A, Ito K, Tamura Y, Yoshida S, Saito Y, Kohn LD 1997 Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor. Thyroid 7:867-877.
24. Nagayama Y, Russo D, Chazenbalk GD, Wadsworth HL, Rapoport B 1990 Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding. Biochem Biophys Res Commun 173:1150-1156.
25. Ho SC, Van Sande J, Lefort A, Vassart G, Costagliola S 2001 Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity. Endocrinology 142:2760-2767.
26. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S 2002 Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 16:736-746.
27. Chazenbalk GD, Jaume JC, McLachlan SM, Rapoport B 1997 Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera. J Biol Chem 272:18959-18965.
28. Grasso YZ, Kim MR, Faiman C, Kohn LD, Tahara K, Gupta MK 1999 Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors. Thyroid 9:531-537.
29. Kung AW, Lau KS, Kohn LD 2001 Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy. J Clin Endocrinol Metab 86:3647-3653.
30. Akamizu T, Kohn LD, Hiratani H, Saijo M, Tahara K, Nakao K 2000 Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: Unique epitopes may contribute to the regulation of thyroid function by the antibodies. J Clin Endocrinol Metab 85:2116-2121.
31. Sanders J, Wills J, Depraetere H, Oda Y, Evans M, Richards T, Kiddie A, Furmaniak J, Rees Smith B 2001 The nature of the TSH receptor's hormone binding site [abstract 136]. J Endocrinol Invest 24:68.
32. Wang SH, Carayanniotis G, Zhang Y, Gupta M, McGregor AM, Banga JP 1998 Induction of thyroiditis in mice with thyrotropin receptor lacking serologically dominant regions. Clin Exp Immunol 113:119-125.
33. Reichert JM 2001 Monoclonal antibodies in the clinic. Nat Biotechnol 19:819-822.